(ABI) Anheuser Busch Inbev - Ratings and Ratios
Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0974293251
ABI EPS (Earnings per Share)
ABI Revenue
ABI: Beer, Spirits, Non-Alcohol Beverages
Anheuser-Busch InBev SA/NV is a global beverage giant with a diverse portfolio of around 500 beer brands, including iconic labels such as Budweiser, Corona Extra, and Stella Artois, as well as a growing presence in the spirits and non-alcoholic beverages market. The companys extensive reach spans across North America, South America, Europe, Africa, and the Asia Pacific, making it one of the largest brewers in the world.
With a rich history dating back to 1366, Anheuser-Busch InBev SA/NV has evolved through strategic mergers and acquisitions, including the notable merger between InBev SA and Anheuser-Busch in 2008. Today, the company is headquartered in Leuven, Belgium, and operates with a global footprint, leveraging its scale and expertise to drive growth and innovation in the beverage industry.
Analyzing the technical data, ABIs stock has been trending upwards, with a current price of 62.04 EUR, above its 20-day SMA of 60.17 EUR and 50-day SMA of 57.58 EUR. The stocks ATR of 0.92 EUR (1.48%) indicates moderate volatility. Given the current technical setup, we can expect the stock to continue its upward momentum, potentially testing new 52-week highs.
From a fundamental perspective, Anheuser-Busch InBev SA/NV boasts a market capitalization of 114.68 billion EUR, with a P/E ratio of 20.01 and a forward P/E of 18.48, indicating a relatively stable valuation. The companys RoE of 8.34% suggests a decent return on equity. Considering the fundamental data, ABIs stable cash flows and diversified portfolio are likely to drive long-term growth, supporting the stocks upward trajectory.
Combining technical and fundamental analysis, our forecast suggests that ABIs stock is likely to continue its upward trend, potentially reaching 65 EUR in the near term, driven by the companys strong brand portfolio, global reach, and stable financials. However, investors should remain vigilant, as the beverage industry is subject to changing consumer preferences and regulatory environments.
Additional Sources for ABI Stock
ABI Stock Overview
Market Cap in USD | 139,067m |
Sector | Consumer Defensive |
Industry | Beverages - Brewers |
GiC Sub-Industry | Brewers |
IPO / Inception |
ABI Stock Ratings
Growth Rating | 32.9 |
Fundamental | 58.8 |
Dividend Rating | 58.2 |
Rel. Strength | -6.29 |
Analysts | - |
Fair Price Momentum | 56.40 EUR |
Fair Price DCF | 136.63 EUR |
ABI Dividends
Dividend Yield 12m | 1.54% |
Yield on Cost 5y | 2.07% |
Annual Growth 5y | 10.42% |
Payout Consistency | 85.8% |
Payout Ratio | 24.4% |
ABI Growth Ratios
Growth Correlation 3m | 79.7% |
Growth Correlation 12m | 31.1% |
Growth Correlation 5y | 44.7% |
CAGR 5y | 6.57% |
CAGR/Max DD 5y | 0.23 |
Sharpe Ratio 12m | 0.43 |
Alpha | 1.50 |
Beta | 0.164 |
Volatility | 22.60% |
Current Volume | 2160.5k |
Average Volume 20d | 1528.2k |
As of July 01, 2025, the stock is trading at EUR 58.24 with a total of 2,160,537 shares traded.
Over the past week, the price has changed by -5.55%, over one month by -5.97%, over three months by +4.10% and over the past year by +8.85%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Anheuser Busch Inbev (BR:ABI) is currently (July 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 58.78 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ABI is around 56.40 EUR . This means that ABI is currently overvalued and has a potential downside of -3.16%.
Anheuser Busch Inbev has no consensus analysts rating.
According to our own proprietary Forecast Model, ABI Anheuser Busch Inbev will be worth about 60.9 in July 2026. The stock is currently trading at 58.24. This means that the stock has a potential upside of +4.58%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 69 | 18.4% |
Analysts Target Price | - | - |
ValueRay Target Price | 60.9 | 4.6% |